Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Shortage reports
Actual shortage:
0 (0%)
Anticipated shortage:
1 (1%)
Avoided shortage:
8 (7%)
Resolved:
98 (92%)
107
Discontinuation Reports
To be discontinued:
1 (17%)
Discontinued:
5 (83%)
Reversed:
0 (0%)
6
0 (0%)
0 (0%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-05-13 | 2022-05-20 | 160522 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-12-14 | 2021-12-17 | 151115 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-09-23 | 2021-10-27 | 146048 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-11-30 | 2023-01-25 | 176387 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2021-03-05 | 2021-03-09 | 135159 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-15 | 122257 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-08-14 | 2020-09-26 | 122250 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2020-07-28 | 2020-09-26 | 121295 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2019-06-19 | 2019-06-22 | 87081 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2019-06-06 | 2019-06-14 | 85726 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-24 | 217417 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2025-04-16 | 2025-04-22 | 255152 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-15 | 217411 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160562 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160540 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160537 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-07 | 160534 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-12 | 2023-03-01 | 160389 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| SEHCAT | 370KBq | CAPSULE | To be discontinued | 2026-02-12 | 2026-02-12 | 277848 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 6 of 6